Phase III Randomized, Placebo-Controlled Study of Acyclovir Oral Suspension for Neonatal Herpes Simplex Virus Infection Limited to the Skin, Eyes, and Mouth

NCT00004757 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

Herpes Simplex

Interventions

DRUG: acyclovir

Sponsor

National Center for Research Resources (NCRR)

Collaborators

[object Object]